C3 and age-related macular degeneration: Recent demonstrations of CFH functions that appear to be independent of its established role as a C3 inhibitor, suggest the existence of novel CFH mechanisms that may contribute to these early AMD biomarkers and the poorly understood early events of disease pathogenesis (13–15).